Cell cycle characteristics in myeloid leukemias
Raza, A.; Khan, S.P.; Mehdi, I.; Imren, S.; Yasin, Z.; Preisler, H.D.
Bone Marrow Transplantation 4(Suppl 1): 26-29
1989
ISSN/ISBN: 0268-3369 PMID: 2713557 Document Number: 339585
Document emailed within 1 workday
Related Documents
Ferrari, S.; Tagliafico, E.; Ceccherelli, G.; Selleri, L.; Calabretta, B.; Donelli, A.; Temperani, P.; Sarti, M.; Sacchi, S.; Emilia, G. 1989: Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes Leukemia 3(6): 423-430Sánchez Fayos, J. 1981: Inducers of cell differentiation in acute myeloid leukemias Sangre 26(5-A): 619-625
Hoda Mohamed A. El-Ghany; El, Z.A.-Saadany; Bahaa, N.M.; Ibrahim, N.Y.; Hussien, S.M. 2014: Stromal Cell Derived Factor-1 (CXCL12) Chemokine Gene Variant in Myeloid Leukemias Clinical Laboratory 2014(5): 10
Gossla, R.; Hartmann, W.; Heit, W.; Gaedicke, G.; Vetter, U. 1990: Role of insulin during cell cycle in a myeloid cell line Leukemia 4(2): 111-116
Willman, C.L. 1999: Molecular evaluation of acute myeloid leukemias Seminars in Hematology 36(4): 390-400
Savchenko, V.G.; Parovichnikova, E.N.; Isaev, V.G.; Kucher, R.A. 1992: The strategy for the therapy of acute myeloid leukemias in adults Terapevticheskii Arkhiv 64(7): 4-17
Tsunogake, S.; Nagashima, S.; Maekawa, R.; Takano, N.; Kajitani, H.; Saito, K.; Enokihara, H.; Furusawa, S.; Shishido, H. 1991: Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia International Journal of Hematology 54(3): 251-256
Crisan, D.; David, D.; DiCarlo, R. 1996: Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias Archives of Pathology and Laboratory Medicine 120(9): 828-834
Bhisey, A.N.; Khare, A.G.; Advani, S.H.; Ranadive, K.J. 1978: Cytogenetic studies in leukemias--blastic crisis of chronic myeloid leukemia Indian Journal of Medical Research 68: 285-294
Dudek, H.; Reddy, E.P. 1989: Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins Oncogene 4(12): 1489-1495
Davey, F.R.; Mick, R.; Nelson, D.A.; MacCallum, J.; Sobol, R.E.; Royston, I.; Cuttner, J.; Ellison, R.R.; Bloomfield, C.D. 1988: Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen Leukemia 2(7): 420-426
Gaĭdukova, S.N.; Guseva, S.A.; Tishchenko, L.M. 1989: Differential diagnostic criteria of blast cells in the peripheral blood in acute myeloid leukemias Vrachebnoe Delo 1989(9): 38-41
Lemez, P.; Maresová, J. 1996: Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias Neoplasma 43(6): 417-419
Michalová, K.; Musilová, J.; Zemanová, Z. 1990: Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. the Czechoslovak MDS Cooperative Group Czechoslovak Medicine 13(4): 133-144
Carulli, G.; Petrini, M.; Marini, A.; Vaglini, F.; Caracciolo, F.; Grassi, B. 1990: P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia Haematologica 75(6): 516-521
Alberts, D.S.; Durie, B.G.; Salmon, S.E. 1977: Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics Cancer Treatment Reports 61(3): 381-388
Wakamiya, N.; Stone, R.; Takeyama, H.; Spriggs, D.; Kufe, D. 1989: Detection of tumor necrosis factor gene expression at a cellular level in human acute myeloid leukemias Leukemia 3(1): 51-56
Legrand, O.; Zompi, S.; Perrot, J-Yves.; Faussat, A-Marie.; Benderra, Z.; Chaoui, D.; Marie, J-Pierre. 2004: P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups Haematologica 89(1): 34-41
Polliack, A.; Leizerowitz, R.; Gazitt, Y. 1987: Phorbol esters and hairy cell leukemia: effects on cell morphology and surface membrane features and comparison with other B cell leukemias Leukemia 1(4): 311-315
Hassan, H.T.; Veit, A.; Maurer, H.R. 1991: Recombinant human GM-CSF significantly enhances the cytostatic activity of cell cycle specific anti-leukaemic drugs in HL-60 human myeloid leukaemia clonogenic cells in a capillary clonogenic micro-assay Anticancer Research 11(1): 481-485